148
Journals
668.9K
Articles
12.3M
Citations
108.5K
Authors

Most Cited Articles of Hematology in 2018

TitleJournalYearCitations
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCa-A Cancer Journal for Clinicians201841.6K
Cancer statistics, 2018Ca-A Cancer Journal for Clinicians201812K
Ovarian cancer statistics, 2018Ca-A Cancer Journal for Clinicians20181.3K
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2018897
Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer SocietyCa-A Cancer Journal for Clinicians2018759
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†Annals of Oncology2018645
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLBlood2018607
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United StatesCa-A Cancer Journal for Clinicians2018537
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologistsAnnals of Oncology2018529
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyBlood2018528
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancerInternational Journal of Clinical Oncology2018503
The biology and role of CD44 in cancer progression: therapeutic implicationsJournal of Hematology and Oncology2018432
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemiaBlood2018382
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerAnnals of Oncology2018376
Next generation of immune checkpoint therapy in cancer: new developments and challengesJournal of Hematology and Oncology2018375
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profileCytokine2018372
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeBlood2018359
CTLA-4: a moving target in immunotherapyBlood2018356
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2018355
The MLL recombinome of acute leukemias in 2017Leukemia2018328
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activityLeukemia2018323
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2018316
Comprehensive analysis of the clinical immuno-oncology landscapeAnnals of Oncology2018311
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screeningCa-A Cancer Journal for Clinicians2018306
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancerAnnals of Oncology2018302